CCL3–CCR5 axis contributes to progression of esophageal squamous cell carcinoma by promoting cell migration and invasion via Akt and ERK pathways

Takayuki Kodama(Kobe University), Hiroshi Yokozaki(Kobe University)
Laboratory Investigation
May 26, 2020
10.1038/s41374-020-0441-4
Cited by 81

Related Papers

Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma
|Laboratory Investigation|2019|171
GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways
|Laboratory Investigation|2015|84
PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages
|Laboratory Investigation|2020|72
CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells
|Oncotarget|2017|69
Cyr61 promotes <scp>CD</scp>204 expression and the migration of macrophages via <scp>MEK</scp>/<scp>ERK</scp> pathway in esophageal squamous cell carcinoma
|Cancer Medicine|2015|33